All Access Articles |
- Structure Therapeutics Appoints Matthew Lang as COO and General Counsel | 2026-04-15 | UNITED STATES
- Structure Therapeutics Reports Positive Phase 2 Data on Aleniglipron | 2026-03-16 | UNITED STATES
- Structure Therapeutics Reports 6.2% Weight Loss in Phase 2a Obesity Study | 2024-06-03 | PHARMACEUTICAL